Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,099 public trials 1,231 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Recruiting

A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma

NCT07297212

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations
  • Beijing Tiantan Hospital, Capital Medical University Beijing, China
  • Affiliated Tumor Hospital of Chongqing Medical University Chongqing, China
  • Affiliated Cancer Hospital of Shandong First Medical University Jinan, China
  • Huashan Hospital, Fudan University Shanghai, China
View Trial Details
Recruiting

The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]

NCT02688894

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +9 more
Locations
  • Gachon University Gil Medical Center Incheon, South Korea
  • Seoul National University Bundang Hospital Seongnam, South Korea
  • Samsung Medical Center Seoul, South Korea
  • VHS Medical Center Seoul, South Korea
View Trial Details
Recruiting

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

NCT02559778

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • University of Alabama/Children's of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Rady Children's Hospital San Diego, California, United States
View all 28 locations
View Trial Details
Recruiting

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

NCT04696029

Conditions
Glioma, Medulloblastoma, Neoplasms, +7 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • Stanford University Stanford, California, United States
View all 24 locations
View Trial Details
Recruiting

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

NCT06413680

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +28 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
  • Yale School of Medicine North Haven, Connecticut, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Recruiting

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

NCT06540963

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
View Trial Details
Recruiting

NK Cell Therapy for Malignant Solid Brain Tumors

NCT07552233

Conditions
Astrocytoma, Brain Diseases, Brain Metastasis, +22 more
Locations
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Qinhuangdao Runze Hospital Qinhuangdao, Hebei, China
  • Zhengzhou Second Hospital Zhengzhou, Henan, China
  • Henan Academy of Innovations in Medical Science Zhengzhou, Henan, China
View Trial Details

Related conditions